97 related articles for article (PubMed ID: 6233397)
1. Prostaglandin-related and adherent cell suppressor system in apparently cured Hodgkin's disease patients.
Haim N; Meidav A; Samuelly B; Segal R; Mekori T; Robinson E
J Biol Response Mod; 1984; 3(2):219-25. PubMed ID: 6233397
[TBL] [Abstract][Full Text] [Related]
2. Depressed T cell proliferative responses in Hodgkin's disease: role of monocyte-mediated suppression via prostaglandins and hydrogen peroxide.
Fisher RI; Bostick-Bruton F
J Immunol; 1982 Oct; 129(4):1770-4. PubMed ID: 6980949
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin-producing suppressor cells in Hodgkin's disease.
Goodwin JS; Messner RP; Bankhurst AD; Peake GT; Saiki JH; Williams RC
N Engl J Med; 1977 Nov; 297(18):963-8. PubMed ID: 409950
[TBL] [Abstract][Full Text] [Related]
4. Studies of cell subpopulations mediating mitogen hyporesponsiveness in patients with Hodgkin's disease.
Sibbitt WL; Bankhurst AD; Williams RC
J Clin Invest; 1978 Jan; 61(1):55-63. PubMed ID: 304068
[TBL] [Abstract][Full Text] [Related]
5. Evidence for the involvement of monocyte-derived toxic oxygen metabolites in the lymphocyte dysfunction of Hodgkin's disease.
Deshazo RD; Ewel C; Londono S; Metzger Z; Hoffeld JT; Oppenheim JJ
Clin Exp Immunol; 1981 Nov; 46(2):313-20. PubMed ID: 7337972
[TBL] [Abstract][Full Text] [Related]
6. Suppressor cells in melanoma and lung cancer: correlation with the clinical stage.
Minassian AA; Kadagidze ZG
Neoplasma; 1983; 30(2):153-8. PubMed ID: 6221196
[TBL] [Abstract][Full Text] [Related]
7. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
Holdstock G; Chastenay BF; Krawitt EL
Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of suppression of the depressed lymphocyte response in lung cancer patients.
Alberola V; González-Molina A; Trenor A; San Martín B; Lluch A; Palau F; Marín J; García-Conde FJ
Allergol Immunopathol (Madr); 1985; 13(3):213-9. PubMed ID: 2931010
[TBL] [Abstract][Full Text] [Related]
9. Three suppressor systems in human blood that modulate lymphoproliferation.
Rice L; Laughter AH; Twomey JJ
J Immunol; 1979 Mar; 122(3):991-6. PubMed ID: 312832
[TBL] [Abstract][Full Text] [Related]
10. In vitro effect of indomethacin on mitogen-induced lymphoproliferative response in lung cancer patients.
Stanojević-Bakić N; Vucković-Dekić L; Susnjar S; Spuzić I
Neoplasma; 1992; 39(2):129-32. PubMed ID: 1326720
[TBL] [Abstract][Full Text] [Related]
11. Indomethacin sensitive suppressor cells in Crohn's disease: a possible role in decreased lymphocyte responsiveness.
Victorino RM
J Clin Lab Immunol; 1983 Aug; 11(4):197-201. PubMed ID: 6230454
[TBL] [Abstract][Full Text] [Related]
12. Impaired lymphocyte transformation in Hodgkin's disease. Evidence for depletion of circulating t-lymphocytes.
Matchett KM; Huang AT; Kremer WB
J Clin Invest; 1973 Aug; 52(8):1908-17. PubMed ID: 4541673
[TBL] [Abstract][Full Text] [Related]
13. [Antibody response in cultures of lymphocytes from patients with Hodgkin's lymphoma: role of monocytes].
Villa ML; Colleoni M; Valenti F; Tondini C; Clerici E
Boll Ist Sieroter Milan; 1987; 66(3):214-21. PubMed ID: 3325076
[TBL] [Abstract][Full Text] [Related]
14. Monocyte PGE2 secretion in Hodgkin's disease and its relation to decreased cellular immunity.
Passwell J; Levanon M; Davidsohn J; Ramot B
Clin Exp Immunol; 1983 Jan; 51(1):61-8. PubMed ID: 6572580
[TBL] [Abstract][Full Text] [Related]
15. Role of prostaglandins on lymphocyte transformation in Crohn's disease.
Echevarría S; Cajigas J; Rodríguez de Lope C; Lozano JL; Pons Romero F
Allergol Immunopathol (Madr); 1989; 17(6):317-21. PubMed ID: 2635833
[TBL] [Abstract][Full Text] [Related]
16. [The influence on PHA-stimulation by inhibition of prostaglandin synthesis in vitro in patients with Hodgkin's disease (author's transl)].
Pees HW; Girmann G; Schwamborn J
Blut; 1980 Apr; 40(4):239-47. PubMed ID: 7370437
[TBL] [Abstract][Full Text] [Related]
17. Increased sensitivity of lymphocytes from patients with Hodgkin's disease to concanavalin A-induced suppressor cells.
Vanhaelen CP; Fisher RI
J Immunol; 1981 Sep; 127(3):1216-20. PubMed ID: 6455471
[No Abstract] [Full Text] [Related]
18. Abnormal indomethacin-sensitive suppression in peripheral blood mononuclear cells of cancer patients restricts augmentation by interleukin-2.
Braun DP; Harris JE
J Biol Response Mod; 1984 Oct; 3(5):533-40. PubMed ID: 6239013
[TBL] [Abstract][Full Text] [Related]
19. Effect of BM 12 531 on in vitro induction of suppressor cells by concanavalin A in cancer patients and normal healthy donors.
Somasundaram R; Advani SH; Shetye MR; Gangal SG
J Clin Lab Immunol; 1986 Jan; 19(1):43-7. PubMed ID: 2939248
[TBL] [Abstract][Full Text] [Related]
20. Role of adherent suppressor cells in the depression of cell-mediated immunity in Hodgkin's disease and lung carcinoma.
Thomas Y; Huchet R; Grandjon D
Ann Immunol (Paris); 1981; 132C(2):167-80. PubMed ID: 6458231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
